Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000080255-25-000570·BIO-TECHNE Corp
Schedule 13G ownership disclosure
BIO-TECHNE CORP COM
COMMON STOCK · CUSIP: 09073M104
Event date: 2025-06-30
- Filing-level shares
- 8,848,150
- Percent of class
- 5.6%
- T. Rowe Price Associates, Inc.
Shares: 8,848,150 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000080255-25-000570
- Form type
- SCHEDULE 13G/A
- Filer
- BIO-TECHNE Corp
- CIK
- CIK 842023
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership